Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Pharmaceutics

• Publication date

  2010-08-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1021/mp900275sPMID 20695463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid).

  2009cited by this paper
• Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Intranasal insulin improves cognition and modulates β-amyloid in early AD

  2008cited by this paper
• Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

  2008cited by this paper
• Complications of Skull Base Surgery: An Analysis of 30 Cases

  2008cited by this paper
• RETRACTED ARTICLE: Recent advances for the treatment of cocaine abuse: Central nervous system immunopharmacotherapy

  2008cited by this paper
• Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

  2008cited by this paper
• Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

  2007cited by this paper
• Using blood brain barrier disruption by methamphetamine for drug delivery

  2007cited by this paper
• Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.

  2007cited by this paper
• Influence of formulation viscosity on drug absorption following nasal application in rats.

  2007cited by this paper
• Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart

  2007cited by this paper
• Classification of spatiotemporal hemodynamics from brain perfusion MR images using expectation‐maximization estimation with finite mixture of multivariate gaussian distributions

  2007cited by this paper
• Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs.

  2007cited by this paper
• Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base

  2006cited by this paper
• Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

  2006cited by this paper
• Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy

  2006cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Intranasal insulin improves memory in humans.

  2004cited by this paper
• Hydroxocobalamin Uptake into the Cerebrospinal Fluid after Nasal and Intravenous Delivery in Rats and Humans

  2003cited by this paper
• Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

  2003cited by this paper
• Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats.

  2003cited by this paper
• Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats.

  2003cited by this paper
• Cadmium-metallothionein interactions in the olfactory pathways of rats and pikes.

  2002cited by this paper
• Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical Setting

  2002cited by this paper
• Sniffing neuropeptides: a transnasal approach to the human brain

  2002cited by this paper
• Relative Neurotropism of a Recombinant Rhabdovirus Expressing a Green Fluorescent Envelope Glycoprotein

  2002cited by this paper
• Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique.

  2000cited by this paper
• Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes.

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Transnasal delivery of 5-fluorouracil to the brain in the rat.

  1999cited by this paper
• In‐vivo Microdialysis Study of the Distribution of Cisplatin into Brain Tumour Tissue after Intracarotid Infusion in Rats With 9L Malignant Glioma

  1997cited by this paper
• Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

  1996cited by this paper
• In vitro and in vivo protein binding of methotrexate assessed by microdialysis.

  1996cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• Direct Drug Transport from the Rat Nasal Cavity to the Cerebrospinal Fluid: the Relation to the Molecular Weight of Drugs

  1995cited by this paper
• Gene delivery into the central nervous system by nasal instillation in rats.

  1995cited by this paper
• The expanding role of quantitative structure-activity relationships (QSAR) in toxicology.

  1995cited by this paper
• Brain-Derived Neurotrophic Factor Protects against Ischemic Cell Damage in Rat Hippocampus

  1994cited by this paper
• Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug

  1994cited by this paper
• High-performance liquid chromatography method for serum methotrexate levels in children with severe steroid-dependent asthma.

  1991cited by this paper
• Olfactory primary neurons as a route of entry for toxic agents into the CNS.

  1991cited by this paper
• The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug.

  1991cited by this paper
• Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

  1991cited by this paper
• Nose-blowing and CSF rhinorrhoea.

  1991cited by this paper
• Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain delivery.

  1990cited by this paper
• Determination of serum methotrexate and 7-hydroxymethotrexate concentrations. Method evaluation showing advantages of high-performance liquid chromatography.

  1985cited by this paper
• Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes.

  1983cited by this paper
• Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.

  1981cited by this paper

• Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery

  2025cites this paper
• Functionalized realgar nanoparticles-doped degradable mesoporous silica nanoparticles loaded with temozolomide for the targeted treatment of glioma.

  2025cites this paper
• Intranasal Drug Delivery: Pathways, Challenges, and Advancements in CNS Targeting

  2025cites this paper
• Drug delivery strategies for paediatric diffuse midline gliomas.

  2025cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• DESIGN AND DEVELOPMENT OF PHYTOSOMAL SOFT NANOPARTICLES FOR LIVER TARGETING

  2023cites this paper
• Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies

  2023cites this paper
• Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.

  2023cites this paper
• Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration

  2022cites this paper
• Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy

  2022influential citation
• Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes.

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery.

  2022cites this paper
• Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.

  2022cites this paper
• Applications of direct nose-to-brain drug delivery in biomedicine, biotechnology, tissue engineering, and immunology

  2021cites this paper
• Intranasal drug delivery: opportunities and toxicologic challenges during drug development

  2021cites this paper
• Enhancement of the Brain Delivery of Methotrexate with Administration of Mid-chain Ester Prodrugs: In vitro and In vivo Studies.

  2021cites this paper
• Controlled Drug Delivery via the Nasal Route

  2021cites this paper
• Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations.

  2020cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders

  2020cites this paper
• Glioma targeted delivery systems

  2019cites this paper
• Mixed Mucoadhesive Amphiphilic Polymeric Nanoparticles Cross a Model of Nasal Septum Epithelium in Vitro.

  2019cites this paper
• How to Make Anticancer Drugs Cross the Blood–Brain Barrier to Treat Brain Metastases

  2019cites this paper
• Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

  2019cites this paper
• 1 Nasal Drug Delivery of Anticancer Drugs for the 2 Treatment of Glioblastoma : Preclinical and Clinical 3 Trials 4

  2019influential citation
• Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi‐center randomized parallel group clinical study

  2019cites this paper
• Nose-to-Brain Delivery

  2019cites this paper
• New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model

  2018cites this paper
• Progress in brain targeting drug delivery system by nasal route

  2017cites this paper
• INTRANASAL ROUTE-AN INNOVATIVE TECHNIQUE FOR BRAIN TARGETTING

  2017cites this paper
• Glioblastoma: To Target the Tumor Cell or the Microenvironment?

  2017cites this paper
• Novel Delivery Strategies

  2017cites this paper
• Challenges of the Nose-to-Brain Route

  2017cites this paper
• Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model

  2017cites this paper
• Nasal delivery of nanoliposome-encapsulated ferric ammonium citrate can increase the iron content of rat brain

  2017cites this paper
• Role of functionalized liposomes in drug delivery through the blood-brain barrier

  2016cites this paper
• Development and characterization of lysine-methotrexate conjugate for enhanced brain delivery

  2016cites this paper
• Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases

  2016influential citation
• Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.

  2016cites this paper
• Blood-brain barrier, cytotoxic chemotherapies and glioblastoma

  2016cites this paper
• Drug delivery approaches for the treatment of glioblastoma multiforme

  2016cites this paper
• Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat.

  2016cites this paper
• Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.

  2016cites this paper
• Formulation and device design to increase nose to brain drug delivery

  2016cites this paper
• Tissue-based in vitro and ex vivo models for nasal permeability studies

  2016cites this paper
• Indirect radio-chemo-beta therapy: a targeted approach to increase biological efficiency of x-rays based on energy

  2015cites this paper
• Development of reversible glutamine conjugate of methotrexate for enhanced brain delivery

  2015cites this paper
• ATPS-29INTRANASAL DELIVERY OF THERAPEUTIC NEURAL STEM CELLS TO TARGET INTRACEREBRAL GLIOMA

  2015cites this paper
• Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.

  2015cites this paper
• Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles

  2015cites this paper
• Intranasal Delivery of Therapeutic Neural Stem Cells to Target Intracerebral Glioma

  2015cites this paper
• Drug transporters in the nasal epithelia and their contribution in drug delivery

  2014cites this paper
• The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.

  2014cites this paper
• A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option

  2014cites this paper
• Nanobiotechnology-based drug delivery in brain targeting.

  2014cites this paper
• Inhibition of Let7c MicroRNA Is Neuroprotective in a Rat Intracerebral Hemorrhage Model

  2014cites this paper
• Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

  2013cites this paper
• Novel therapeutic delivery approaches in development for pediatric gliomas.

  2013cites this paper
• Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression.

  2012cites this paper
• Nanonization of methotrexate by solution-enhanced dispersion by supercritical CO2

  2012cites this paper
• CNS Delivery of Drugs: Challenges and Chances

  2012cites this paper
• Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.

  2012cites this paper
• Methotrexate-loaded microspheres for nose to brain delivery: in vitro/in vivo evaluation

  2012cites this paper
• Intranasal administration: a prospective drug delivery route to the brain

  2012cites this paper
• Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration.

  2012cites this paper
• An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors

  2012cites this paper
• Intranasal delivery of stem cells to the brain

  2011cites this paper
• New Therapeutic Strategies for the Treatment of Brain Tumor

  2011cites this paper
• Intranasal route: An innovative technique for brain targeting

  year unknowncites this paper